BACR Annual Meeting 2023

Circadian cycle, chronobiology and cancer

 


Program          Registration          Abstract          Venue           Sponsors


THE ONLINE ABSTRACT BOOK WILL BE AVAILABLE HERE.
Scientific committee: BACR Board

9:00 Registration, poster mounting & coffee
9:30 – 12:15 MORNING SESSION
Chair: Prof. Olivier Feron
9:30 Introduction (local organizers)
9:45
Zai Diamantopoulou, Cancer Research UK, Beatson Institute, Glasgow, UK
The metastatic spread of breast cancer accelerates during sleep
10:30
Eva Hadadi, Laboratory of Cellular and Molecular Immunology (CMIM), VUB; Lab of Dendritic Cell Biology and Cancer Immunotherapy (DCBCI) & Laboratory for Myeloid Cell Immunology (MCI), VIB IRC, Brussels, Belgium
Circadian clock machinery in anti-tumor immunity
11:00 – 11:30 Coffee break & Poster viewing
11:30 Young investigators: oral presentations of 4 selected abstracts

Eva Blondeel (Ugent),
Time-induced tissue dynamics impact spheroid heterogeneity and drug responses: consequences for functional precision medicine drug screenings.

Rebekah Crake (ULiège), Identifying targetable metabolic adaptations in drug tolerant BRAFV600E mutant non-small cell lung cancer.

Tias Verhezen (UAntwerp), Prevention of hypoxia-induced natural killer cell dysfunction through maintenance of mitochondrial health.

Morgane Paque (ULiège), mTORC2-dependent reprogramming of lipid metabolism supports lung cancer progression.

12:30 BACR: general assembly (members only)
12:30 – 14:15 LUNCH AND POSTER SESSION
14:15 – 17:00 AFTERNOON SESSION
Chair: Prof. Akeila Bellahcène
14:15 Young investigators: oral presentations of 4 selected abstracts

Lisa Kerkhove (VUB), Role of ferroptosis in radiation-induced cell death.

Charline Degavre (UCLouvain), In situ photodynamic therapy induction of immunogenic cell death to boost dendritic cellbased immunotherapy of peritoneal carcinomatosis.

Astrid Van den Eynde (UAntwerp), CD70 holds great therapeutic potential to target tumor cells and cancer-associated fibroblasts in the microenvironment by IL-15 boosted CD70-CAR natural killer cells.

Raphaël Peiffer (ULiège), Myoferlin, a new drug target in pancreatic CAFs to tackle desmoplasia and tumor aggressiveness.

15:15 Coffee break
15:45
Zeng Qun, Department of Pathology and Immunology, Centre Médical Universitaire (CMU), University of Geneva, Switzerland
Cancer chronotherapy through the targeting of the circadian immune system
16:15
Léo Aubert, Cancer Translational Research Lab, IREC, UCLouvain, Brussels, Belgium
Deciphering the interplay between circadian rhythms and cancer cell metabolism
16:45 Awards ceremony for best oral and poster presentations
Concluding remarks
17:00 End of conference